AIF1 and neoplasm: These data demonstrate that H-FIRE, a novel nonthermal tumor ablation therapeutic, alters the proteomic payloads of extracellular vesicles, which then exhibit increased retention in the brain, endothelial cell tropism, and correlation with increased infiltration of Iba1+ cells.